Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2018.11.063
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

Reply to “Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?”

Journal of the American Academy of Dermatology
Dermatology
2019English

Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma

American Journal of Clinical Dermatology
DermatologyMedicine
2019English

Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

But Will It Help My Patients With Myocardial Infarction?

BMJ
1982English

“How Will It Help Me?”

Journal of Nervous and Mental Disease
PsychiatryMental Health
2013English

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Clinical Validation of a Prognostic 11-Gene Expression Profiling Score in Prospectively Collected FFPE Tissue of Patients With AJCC V8 Stage II Cutaneous Melanoma

European Journal of Cancer
Cancer ResearchOncology
2020English

Prognostic Metabolic Markers in Cutaneous Melanoma

British Journal of Dermatology
DermatologyMedicine
2019English

Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy